Position in VCEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$692,709
+$527,003 QoQ
Shares Held
15,570
+202.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#158
of 315 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 15%
Shared 85%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIRTUS ADVISERS, LLC holds $9,287,940 across 18 Biotechnology names. VCEL ranks #6 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
44,384 | $1,122,914 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
29,253 | $1,065,101 | |
| 3 | EXEL |
Exelixis, Inc.
|
14,769 | $803,581 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
9,249 | $753,885 | |
| 5 | INVA |
Innoviva, Inc.
|
30,614 | $695,243 | |
| 6 | VCEL |
Vericel Corp
This page
|
15,570 | $692,709 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
18,007 | $637,267 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
27,098 | $486,950 |
All Filings in VCEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $692,709 | 15,570 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $165,706 | 5,151 | Shares | Other | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||